TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
N/A
Progressive destruction of the lungs is the main cause of shortened life ex...
Status
Completed
Location
Erasmus MC - Sophia Children's Hospital
Start Date
2022-03-21
Trial ID
NCT05752019
A Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Particpants 6 Years and Older and F/MF Genotypes
PHASE3
The study evaluates the long-term safety and efficacy of elexacaftor (ELX)/...
A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes
PHASE3
This study will evaluate the efficacy and safety of elexacaftor (ELX) / tez...
A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
PHASE3
This study will evaluate the efficacy, safety and pharmacodynamics of elexa...